BioIntelliSense
Brian Demcher has over 20 years of work experience in various roles and industries. Brian currently serves as the Director of Client Strategy & Growth at BioIntelliSense, Inc, where they are responsible for developing and implementing strategies to drive client growth. Prior to this, Brian worked as a Senior Director - Strategic Venture Solutions at BioReference Laboratories, where they played a key role in identifying and implementing strategic solutions.
Before joining BioReference Laboratories, Brian held multiple positions at Viracor Eurofins Clinical Diagnostics, including Regional Business Manager and Account Executive. In these roles, they successfully led sales teams, achieved sales targets, and generated significant revenue growth.
Earlier in their career, Brian worked as an Account Executive at Myriad Genetics, where they focused on sales of hereditary cancer screening and diagnostic tests. Brian also had successful sales roles at Medtronic, Boston Scientific, and Johnson & Johnson (Ethicon), where they consistently exceeded sales targets and received recognition for their performance.
Brian's career began in the US Army, where they served as a US Army Officer and held various leadership positions. During their time in the army, they gained valuable experience in intelligence analysis, logistics management, and strategic planning.
Brian Demcher attended the United States Military Academy at West Point, where they pursued a Bachelor of Science (BS) degree in Economics. Brian completed their studies and graduated from this institution in the year 2000.
This person is not in any teams
This person is not in any offices
BioIntelliSense
1 followers
BioIntelliSense has enabled medical-grade Remote Patient Monitoring Hospital at Home (RPM-H@H) via its BioSticker-based data service. The BioSticker™ is an FDA-cleared 510k class II wearable medical device that enables at-home continuous monitoring of vital signs and symptoms directly associated with COVID-19 (temperature, respiratory rate at rest, and coughing frequency) for 30 days on a single device without recharging.